Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phase 3
Clinical Trial to Evaluate the Efficacy and Safety of YYC301 in Patients with Osteoarthritis
of the Knee Joint